Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diversified Healthcare Trust (DHCNL) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Diversified Healthcare Trust (DHCNL) over the last 17 years, with Q3 2025 value amounting to $240.4 million.

  • Diversified Healthcare Trust's Shares Outstanding (Weighted Average) rose 29.96% to $240.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.4 million, marking a year-over-year increase of 29.96%. This contributed to the annual value of $239.5 million for FY2024, which is 29.27% up from last year.
  • Diversified Healthcare Trust's Shares Outstanding (Weighted Average) amounted to $240.4 million in Q3 2025, which was up 29.96% from $240.1 million recorded in Q2 2025.
  • Diversified Healthcare Trust's Shares Outstanding (Weighted Average)'s 5-year high stood at $240.4 million during Q3 2025, with a 5-year trough of $237.8 million in Q1 2021.
  • In the last 5 years, Diversified Healthcare Trust's Shares Outstanding (Weighted Average) had a median value of $238.7 million in 2023 and averaged $238.8 million.
  • In the last 5 years, Diversified Healthcare Trust's Shares Outstanding (Weighted Average) grew by 6.94% in 2021 and then surged by 33.68% in 2025.
  • Over the past 5 years, Diversified Healthcare Trust's Shares Outstanding (Weighted Average) (Quarter) stood at $238.0 million in 2021, then grew by 0.15% to $238.3 million in 2022, then rose by 0.22% to $238.8 million in 2023, then rose by 0.29% to $239.5 million in 2024, then rose by 0.35% to $240.4 million in 2025.
  • Its last three reported values are $240.4 million in Q3 2025, $240.1 million for Q2 2025, and $240.0 million during Q1 2025.